GDS Technology, Inc.

Elkhart, IN 46514
14 Employees

SBIR Award Summary

Total Number of Awards 12
Total Value of Awards $47.9K
First Award Date 01/01/88
Most Recent Award Date 09/01/96

Key Personnel

Last Name Name Awards Contact
deCASTRO Dr. AURORA F deCASTRO 1
De Castro Aurora F De Castro 9
Gupta Surendra K Gupta 2

12 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/96 - 07/31/97

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/96 - 08/15/97

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/92 - 10/30/92

DESCRIPTION: (Adapted from the applicant's abstract) Theophylline, a drug used by 6-10 million patients, needs to be monitored closely in blood for effective management of asthmatic, allergic, and other bronchospastic conditions. Current tests for theophylline are based on expensive antigen-antibody technologies. Health insurance reimbursemen...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/20/91 - 02/28/92

D-3-Hydroxybutyrate (HB) is a primary metabolite in diabetic keto-acidosis, alcoholism, or starvation. The untreated ketoacidosis can result in coma or death. The current test for ketosis measures only acetoacetate, which is a minor ketoacid and is unstable. Therefore, the test sometimes leads to an error in diagnosis. A simple, quick strip-...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/91 - 04/30/92

DESCRIPTION: (Adapted from the applicant's abstract) Theophylline, a drug used by 6-10 million patients, needs to be monitored closely in blood for effective management of asthmatic, allergic, and other bronchospastic conditions. Current tests for theophylline are based on expensive antigen-antibody technologies. Health insurance reimbursemen...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/90 - 08/31/91

D-3-Hydroxybutyrate (HB) is a primary metabolite in diabetic keto-acidosis, alcoholism, or starvation. The untreated ketoacidosis can result in coma or death. The current test for ketosis measures only acetoacetate, which is a minor ketoacid and is unstable. Therefore, the test sometimes leads to an error in diagnosis. A simple, quick strip-...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/90 - 02/28/91

Children suffering from galactosemia, a genetic disorder, do not have the ability to digest milk and accumulate galactose in blood. Galactosemia leads to cataracts, mental retardation, liver and renal damage, and even death. Because of its severity, in most developed countries, newborns are screened for galactosemia, in addition to phenylketon...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/90 - 12/31/90

Phenylalanine is the metabolite which accumulates in phenylketonuria (PKU), a genetic disorder. Undetected, phenylketonuria in newborns can result in brain damage and behavioral problems. Current tests to detect this severe disease are generally done in a few laboratories to which the blood samples are sent with unavoidable delay of results. ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/89 - 11/30/89

D-3-hydroxybutyrate (HB) is a primary metabolite in diabetic ketoacidosis, alcoholism, or starvation. The untreated ketoacidosis can result in coma or death. The current tests for ketosis measure only acetoacetate (AA), which is a minor ketoacid and is unstable therefore, sometimes leads to error of diagnosis. Therefore, a simple, quick strip...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/88 - 03/30/89

Theophylline is a drug currently used by most asthmatic/allergic adults and children, constituting over six million patients. Therapy requires frequent monitoring of theophylline levels in blood as it causes toxicity at concentrations higher than 20 mg/L and is ineffective at lower than 10 mg/L. Current testing is done in hospital/commercial la...

Load More